Anti-myeloma activity of MELK inhibitor OTS167: effects on drug-resistant myeloma cells and putative myeloma stem cell replenishment of malignant plasma cells

Detalles Bibliográficos
Autores principales: Stefka, A T, Park, J-H, Matsuo, Y, Chung, S, Nakamura, Y, Jakubowiak, A J, Rosebeck, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022182/
https://www.ncbi.nlm.nih.gov/pubmed/27540718
http://dx.doi.org/10.1038/bcj.2016.71
_version_ 1782453472837238784
author Stefka, A T
Park, J-H
Matsuo, Y
Chung, S
Nakamura, Y
Jakubowiak, A J
Rosebeck, S
author_facet Stefka, A T
Park, J-H
Matsuo, Y
Chung, S
Nakamura, Y
Jakubowiak, A J
Rosebeck, S
author_sort Stefka, A T
collection PubMed
description
format Online
Article
Text
id pubmed-5022182
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-50221822016-09-20 Anti-myeloma activity of MELK inhibitor OTS167: effects on drug-resistant myeloma cells and putative myeloma stem cell replenishment of malignant plasma cells Stefka, A T Park, J-H Matsuo, Y Chung, S Nakamura, Y Jakubowiak, A J Rosebeck, S Blood Cancer J Letter to the Editor Nature Publishing Group 2016-08 2016-08-19 /pmc/articles/PMC5022182/ /pubmed/27540718 http://dx.doi.org/10.1038/bcj.2016.71 Text en Copyright © 2016 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Letter to the Editor
Stefka, A T
Park, J-H
Matsuo, Y
Chung, S
Nakamura, Y
Jakubowiak, A J
Rosebeck, S
Anti-myeloma activity of MELK inhibitor OTS167: effects on drug-resistant myeloma cells and putative myeloma stem cell replenishment of malignant plasma cells
title Anti-myeloma activity of MELK inhibitor OTS167: effects on drug-resistant myeloma cells and putative myeloma stem cell replenishment of malignant plasma cells
title_full Anti-myeloma activity of MELK inhibitor OTS167: effects on drug-resistant myeloma cells and putative myeloma stem cell replenishment of malignant plasma cells
title_fullStr Anti-myeloma activity of MELK inhibitor OTS167: effects on drug-resistant myeloma cells and putative myeloma stem cell replenishment of malignant plasma cells
title_full_unstemmed Anti-myeloma activity of MELK inhibitor OTS167: effects on drug-resistant myeloma cells and putative myeloma stem cell replenishment of malignant plasma cells
title_short Anti-myeloma activity of MELK inhibitor OTS167: effects on drug-resistant myeloma cells and putative myeloma stem cell replenishment of malignant plasma cells
title_sort anti-myeloma activity of melk inhibitor ots167: effects on drug-resistant myeloma cells and putative myeloma stem cell replenishment of malignant plasma cells
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022182/
https://www.ncbi.nlm.nih.gov/pubmed/27540718
http://dx.doi.org/10.1038/bcj.2016.71
work_keys_str_mv AT stefkaat antimyelomaactivityofmelkinhibitorots167effectsondrugresistantmyelomacellsandputativemyelomastemcellreplenishmentofmalignantplasmacells
AT parkjh antimyelomaactivityofmelkinhibitorots167effectsondrugresistantmyelomacellsandputativemyelomastemcellreplenishmentofmalignantplasmacells
AT matsuoy antimyelomaactivityofmelkinhibitorots167effectsondrugresistantmyelomacellsandputativemyelomastemcellreplenishmentofmalignantplasmacells
AT chungs antimyelomaactivityofmelkinhibitorots167effectsondrugresistantmyelomacellsandputativemyelomastemcellreplenishmentofmalignantplasmacells
AT nakamuray antimyelomaactivityofmelkinhibitorots167effectsondrugresistantmyelomacellsandputativemyelomastemcellreplenishmentofmalignantplasmacells
AT jakubowiakaj antimyelomaactivityofmelkinhibitorots167effectsondrugresistantmyelomacellsandputativemyelomastemcellreplenishmentofmalignantplasmacells
AT rosebecks antimyelomaactivityofmelkinhibitorots167effectsondrugresistantmyelomacellsandputativemyelomastemcellreplenishmentofmalignantplasmacells

Ejemplares similares